Arcontech Group PLC Result of AGM (0198S)
September 27 2017 - 12:23PM
UK Regulatory
TIDMARC
RNS Number : 0198S
Arcontech Group PLC
27 September 2017
AorTech International plc
("AorTech"or the "Company")
Result of AGM
AorTech International plc (AIM: AOR), the biomaterials and
medical device IP company, is pleased to announce that at the
Annual General Meeting held today, all the resolutions were duly
passed.
For further information contact:
AorTech International plc
Eddie McDaid, Chief Executive Tel: +44 (0)7802 920869
AorTech International plc
Bill Brown, Chairman Tel: +44 (0)7730 718296
finnCap Limited
Jonny Franklin-Adams / Giles Rolls Tel: +44 20 7220 0500
About AorTech:
AorTech has developed biostable, implantable polymers, including
Elast-Eon(TM) and ECSil(TM) the world's leading long-term
implantable co-polymers, now manufactured on their behalf by
Biomerics LLC in Utah, USA. With several million implants and seven
years of successful clinical use, AorTech polymers are being
developed and used in cardiology and urological applications,
including pacing leads, cardiac cannulae, stents and neuro
stimulation devices. Devices manufactured from AorTech polymers
have numerous US FDA PMA approvals, 510k's, CE Marks, Australian
TGA and Japanese Ministry of Health approvals.
Elast-Eon(TM) and ECSil(TM)'s biostability is comparable to
silicone while exhibiting excellent mechanical, blood contacting
and flex-fatigue properties. These polymers can be processed using
conventional thermoplastic extrusion and moulding techniques. A
range of materials in a variety of application-specific
formulations for use in medical devices and components are
available.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGOKODBABKDBCB
(END) Dow Jones Newswires
September 27, 2017 12:23 ET (16:23 GMT)
Arcontech (LSE:ARC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Arcontech (LSE:ARC)
Historical Stock Chart
From Sep 2023 to Sep 2024